Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Brian R Hearn
Affiliation
Department of Pharmaceutical Chemistry and, University of California san francisco
ORCID
Career Start Year
2002
Papers
22
H Index
13
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
33822591
Attenuation of the Reaction of Michael Acceptors with Biologically Important Nucleophiles.
Bioconjug Chem
2021
32302100
Cyanopyrrolidine Inhibitors of Ubiquitin Specific Protease 7 Mediate Desulfhydration of the Active-Site Cysteine.
ACS Chem Biol
2020
31744896
PET Imaging of the EPR Effect in Tumor Xenografts Using Small 15 nm Diameter Polyethylene Glycols Labeled with Zirconium-89.
Mol Cancer Ther
2020
29249604
Selectively Modulating Conformational States of USP7 Catalytic Domain for Activation.
Structure
2018
29577950
Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system.
J Control Release
2018
27149244
Surgical sealants with tunable swelling, burst pressures, and biodegradation rates.
J Biomed Mater Res B Appl Biomater
2017
29045385
USP7 small-molecule inhibitors interfere with ubiquitin binding.
Nature
2017
28605180
A Hydrogel-Microsphere Drug Delivery System That Supports Once-Monthly Administration of a GLP-1 Receptor Agonist.
ACS Chem Biol
2017
26789650
Structure-Activity Studies of Bis-O-Arylglycolamides: Inhibitors of the Integrated Stress Response.
ChemMedChem
2016
27657443
Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake.
Bioconjug Chem
2016
27435960
Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6α branch.
Elife
2016
25584814
Biodegradable tetra-PEG hydrogels as carriers for a releasable drug delivery system.
Bioconjug Chem
2015
25875391
Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response.
Elife
2015
24259468
Tailoring small molecules for an allosteric site on procaspase-6.
ChemMedChem
2014
24977643
Broad-spectrum allosteric inhibition of herpesvirus proteases.
Biochemistry
2014
23741617
Pharmacological brake-release of mRNA translation enhances cognitive memory.
Elife
2013
22394492
Predicting and improving the membrane permeability of peptidic small molecules.
J Med Chem
2012
23227217
Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6.
PLoS One
2012
17691074
Semisynthesis and cytotoxicity of hypothemycin analogues.
ChemMedChem
2007
16441089
Methanolysis products of disorazole A1.
J Nat Prod
2006
16805551
C-15 thiazol-4-yl analogues of (E)-9,10-didehydroepothilone D: synthesis and cytotoxicity.
Org Lett
2006
12182597
A divergent approach to the myriaporones and tedanolide: completion of the carbon skeleton of myriaporone 1.
Org Lett
2002
1 - 22 of 22
Column Actions
Search
Recommended Authors
Phillip P Sharp
University of California san francisco
Career Start Year
2013
Number of shared co-authors
3
Daniel Carbajo
Institut de Quimica Avancada de Catalunya (IQAC-CSIC)
Career Start Year
2011
Number of shared co-authors
0
Kevin Lou
Howard Hughes Medical Institute, University of California san francisco
Career Start Year
2007
Number of shared co-authors
3
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year
2007
Number of shared co-authors
0
Xin Cong
Jiangsu Simcere Pharmaceutical Co. Ltd.
Career Start Year
2004
Number of shared co-authors
2
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year
2003
Number of shared co-authors
0
Xiaoguang Lei
Peking-Tsinghua Center for Life Sciences, Peking University
Career Start Year
2003
Number of shared co-authors
0
Luke L Lairson
The Scripps Research Institute
Career Start Year
2003
Number of shared co-authors
0
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
0
Daniel A Harki
University of Minnesota
Career Start Year
2002
Number of shared co-authors
2
Matthew H Todd
School of Pharmacy, University College London
Career Start Year
2001
Number of shared co-authors
0
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Career Start Year
2001
Number of shared co-authors
2
R Scott Lokey
University of California Santa Cruz
Career Start Year
2000
Number of shared co-authors
2
Rima Al-Awar
Ontario Institute for Cancer Research, University Avenue
Career Start Year
1999
Number of shared co-authors
0
William McCoull
Oncology R&D
Career Start Year
1999
Number of shared co-authors
0
Jian Jin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year
1998
Number of shared co-authors
1
Praveen Kumar Vemula
Institute for Stem Cell Science and Regenerative Medicine (InStem)
Career Start Year
1998
Number of shared co-authors
0
Fei Liu
Macquarie University
Career Start Year
1998
Number of shared co-authors
0
Sharad K Verma
Johns Hopkins University
Career Start Year
1998
Number of shared co-authors
0
Rodrigo J Carbajo
Oncology R&D
Career Start Year
1997
Number of shared co-authors
0
Anne Marinier
Institute for Research in Immunology and Cancer
Career Start Year
1997
Number of shared co-authors
0
Jack Taunton
University of California san francisco
Career Start Year
1996
Number of shared co-authors
5
Paul J Hergenrother
University of Illinois at Urbana-Champaign
Career Start Year
1995
Number of shared co-authors
1
Michael Ohlmeyer
Atux Iskay LLC
Career Start Year
1993
Number of shared co-authors
1
Timothy A Lewis
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1990
Number of shared co-authors
0
Mark Namchuk
Blavatnik Institute, Harvard Medical School
Career Start Year
1990
Number of shared co-authors
0
David Uehling
Ontario Institute for Cancer Research, University Avenue
Career Start Year
1989
Number of shared co-authors
0
Sally Freeman
Division of Pharmacy and Optometry, University of Manchester
Career Start Year
1988
Number of shared co-authors
0
Joel Morris
National Cancer Institute
Career Start Year
1986
Number of shared co-authors
0
Stuart L Schreiber
Broad Institute
Career Start Year
1985
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Adam R Renslo
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
10
Priyadarshini Jaishankar
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
8
Peter Walter
University of California san francisco
Co-authored papers
4
Punitha Vedantham
Department of Pharmaceutical Chemistry and, University of California san francisco
Co-authored papers
4
Carmela Sidrauski
Calico Life Sciences LLC
Co-authored papers
3
Jordan C Tsai
University of California san francisco
Co-authored papers
2
Jonathan E Gable
Novartis Institute for Tropical Diseases
Co-authored papers
1
Edward L Tang
Co-authored papers
1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers
1
Erik Verschueren
University of California San Francisco
Co-authored papers
1
Christopher S Fraser
College of Biological Sciences, University of California davis
Co-authored papers
1
Matthew P Jacobson
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
1
Charles S Craik
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
1
Aaron S Mendez
University of California Berkeley
Co-authored papers
1
Dario R Alessi
University of Dundee
Co-authored papers
1
Masaaki Sokabe
College of Biological Sciences, University of California davis
Co-authored papers
1
Jonathan S Weissman
Whitehead Institute for Biomedical Research
Co-authored papers
1
Martin Kampmann
Institute for Neurodegenerative Diseases, University of California san francisco
Co-authored papers
1
Billy W Newton
University of California San Francisco
Co-authored papers
1
1 - 20